Among those, preclinical studies have shown that hypodiploid ALL cells are sensitive to Phosphoinositide 3-kinase (PI3K) and BCL2 Apoptosis Regulator (BCL2) inhibitors [27,34]. Here, BCL2 is linked to acute lymphoblastic leukemia.